UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000039345
Receipt number R000044875
Scientific Title alidation study of cancer-related diagnosis and outcomes on Japanese electronic medical records
Date of disclosure of the study information 2020/02/03
Last modified on 2022/08/05 16:49:43

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

validation study of cancer-related diagnosis and outcomes on Japanese electronic medical records

Acronym

validation study of oncology disease area

Scientific Title

alidation study of cancer-related diagnosis and outcomes on Japanese electronic medical records

Scientific Title:Acronym

validation study of oncology disease area

Region

Japan


Condition

Condition

Cancer

Classification by specialty

Gastroenterology Pneumology Hematology and clinical oncology
Gastrointestinal surgery Chest surgery Breast surgery
Obstetrics and Gynecology Urology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To develop algorithms for identifying patients with Cancer and related outcomes in the Real World Data (RWD) database

Basic objectives2

Others

Basic objectives -Others

Sensitivity, specificity, positive predictive value, and negative predictive value of cancer-related outcomes

Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Sensitivity, specificity, positive predictive value, and negative predictive value of cancer related outcomes

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Not applicable

Key exclusion criteria

Not applicable

Target sample size

450


Research contact person

Name of lead principal investigator

1st name Takashi
Middle name
Last name Kanemitsu

Organization

CHUGAI PHARMACEUTICAL CO., LTD.

Division name

Medical Affairs

Zip code

103-8324

Address

1-1 Nihonbashi-Muromach 2-chome, Chuo-ku Tokyo

TEL

03-3273-0833

Email

kanemitsutks@chugai-pharm.co.jp


Public contact

Name of contact person

1st name Takashi
Middle name
Last name Kanemitsu

Organization

CHUGAI PHARMACEUTICAL CO., LTD.

Division name

Medical Affairs

Zip code

103-8324

Address

1-1 Nihonbashi-Muromach 2-chome, Chuo-ku Tokyo

TEL

03-3273-0833

Homepage URL


Email

kanemitsutks@chugai-pharm.co.jp


Sponsor or person

Institute

Kurashiki Central Hospital, Kurashiki

Institute

Department

Personal name



Funding Source

Organization

Chugai Pharmaceutical Co., Ltd

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Research Institute of Healthcare Data Science

Address

12th floor, Sumitomo Shiba Daimon Building 2-5-5 Shiba Daimon, Minato-ku, Tokyo, Japan

Tel

03-5733-5010

Email

rihds@jmdc.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 02 Month 03 Day


Related information

URL releasing protocol

https://bmjopen.bmj.com/content/12/7/e055459.long

Publication of results

Published


Result

URL related to results and publications

https://bmjopen.bmj.com/content/12/7/e055459.long

Number of participants that the trial has enrolled

450

Results

https://bmjopen.bmj.com/content/12/7/e055459.long

Results date posted

2022 Year 08 Month 05 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results

2022 Year 07 Month 13 Day

Baseline Characteristics

https://bmjopen.bmj.com/content/12/7/e055459.long

Participant flow

https://bmjopen.bmj.com/content/12/7/e055459.long

Adverse events

https://bmjopen.bmj.com/content/12/7/e055459.long

Outcome measures

https://bmjopen.bmj.com/content/12/7/e055459.long

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2019 Year 12 Month 28 Day

Date of IRB

2020 Year 01 Month 17 Day

Anticipated trial start date

2020 Year 01 Month 17 Day

Last follow-up date

2020 Year 03 Month 31 Day

Date of closure to data entry

2020 Year 04 Month 08 Day

Date trial data considered complete

2020 Year 08 Month 31 Day

Date analysis concluded

2020 Year 12 Month 16 Day


Other

Other related information

None


Management information

Registered date

2020 Year 01 Month 31 Day

Last modified on

2022 Year 08 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044875


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name